A a medical profession, we should consider striking a middle ground between those calling for a complete ban on the sport and those advocating freedom of choice.
When it comes to treating head and neck tumors, the more information that is available, the better. In the past, options for investigating these types of tumors and their aggressiveness were limited. But advances in optical imaging, positron emission tomography (PET) scanning, magnetic resonance imaging (MRI) and fluorescent and ultrasound imaging have some otolaryngologists excited about the prospect of getting a better look at head and neck cancer.
When patients with allergic rhinitis don’t respond to medical therapy, an otolaryngologist’s arsenal of treatment includes surgical options. Among these is radiofrequency (RF) turbinate reduction, also known as RF turbinate ablation or turbinoplasty, an office procedure that advocates say is cost-effective and minimally invasive, with fewer complications than other surgical remedies. Some otolaryngologists, however, are still hesitant to use this relatively new therapy.
The newly adopted clinical practice guidelines (CPG) on hoarseness—and concerns that portions are overly simplistic and could harm care—took center stage here in a panel discussion at the Annual Meeting of the American Society of Pediatric Otolaryngology, part of the Combined Otolaryngology Spring Meetings held here April 28-May 2.
A test that measures in real time how a noise stimulus on one side affects contralateral otoacoustic emissions (OAEs) could be a new, more accurate predictor of hearing in newborns, according to award-winning research presented at the Annual Meeting of the Triological Society, part of the Combined Otolaryngology Spring Meetings held here April 28-May 2.
An airway clinic jointly staffed by an otolaryngologist and a pulmonologist in Salt Lake City acts as a model for the future care of airway disorders, according to a presentation given at the Annual Meeting of the American Broncho-Esophagological Association (ABEA), part of the Combined Otolaryngology Spring Meetings (COSM) held here April 28-May 2.
Since the advent of the cochlear implant more than 20 years ago, the devices have benefited thousands of patients. According to the U.S. Food and Drug Administration, as of April 2009, approximately 188,000 people worldwide have received cochlear implants. In the U.S., about 42,000 adults and 26,000 children have received them. Today, the fantasy of two implanted artificial cochlea is a reality.
Triological Society members should constantly be assessing their contributions to their profession and working to create meaningful legacies in line with the group’s traditions, said Society President Frank E. Lucente, MD, in his presidential address at the Annual Meeting of the society, part of the Combined Otolaryngology Spring Meetings held here April 28-May 2.